0001213900-19-019994.txt : 20191008 0001213900-19-019994.hdr.sgml : 20191008 20191008164138 ACCESSION NUMBER: 0001213900-19-019994 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191008 DATE AS OF CHANGE: 20191008 EFFECTIVENESS DATE: 20191008 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RELMADA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001553643 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455401931 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-350641 FILM NUMBER: 191143133 BUSINESS ADDRESS: STREET 1: 880 3RD AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 646 876 3459 MAIL ADDRESS: STREET 1: 880 3RD AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: CAMP NINE, INC. DATE OF NAME CHANGE: 20120706 D 1 primary_doc.xml X0708 D LIVE 0001553643 RELMADA THERAPEUTICS, INC. 880 3RD AVENUE, 12TH FLOOR NEW YORK NY NEW YORK 10022 646 876 3459 NEVADA Camp Nine, Inc. CAMP NINE, INC. Corporation true Sergio Traversa 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Executive Officer Director CEO Chuck Ence 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Executive Officer Chief Financial Officer Charles Casamento 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Director Chairman of the Board Paul Kelly 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Director Maged Shenouda 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Director Ottavio Vitolo 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Executive Officer Chief Medical Officer Biotechnology No Revenues 06b false 2019-09-23 false true false 10000 None None None None NONE NONE NONE XX Unknown 00000 FL FLORIDA MD MARYLAND NJ NEW JERSEY NY NEW YORK false 825750 825750 0 false 7 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false RELMADA THERAPEUTICS, INC. /s/ Sergio Traversa Sergio Traversa CEO 2019-10-08